A Mild Method for the Efficient [3,3]-Sigmatropic Rearrangement of <i>N,O</i>-Diacylhydroxylamines

A mild, general method for the [3,3]-sigmatropic rearrangement of N,O-diacylhydroxylamines, employing a combination of mild base and Lewis acid, is described. Employing stoichiometric amounts of reagents with respect to substrate provides α-acyloxyamides, whereas an excess of reagents favors formation of cyclic orthoamides

Surface Plasmon Resonance Assay for Chloramphenicol

We report a rapid and ultrasensitive surface plasmon resonance (SPR) assay of chloramphenicol (CAP) by using large gold nanoparticles (40 nm) for signal enhancement on a mixed self-assembled monolayer (mSAM) sensor surface. After immobilization of the target antibiotic CAP through its ovalbumin (OVA) conjugates with an oligoethylene glycol (OEG) linker on the mSAM surface, sequential binding of anti-CAP antibody and IgG/nanogold (40 nm) onto the sensor surface afforded a rapid (<10 min) and ultrasensitive assay format for CAP. A limit of detection (LOD) for CAP as low as 0.74 fg/mL was achieved in aqueous buffer, and the linear working range was between 1−1000 fg/mL. While the LOD of CAP in a honey spiked-specimen is 17.5 fg/mL, the detection range is 80−5000 fg/mL. The mSAM sensor surface was also shown to be highly stable with over 400 binding/regeneration cycles performed

Combined Mass and Structural Kinetic Analysis of Multistate Antimicrobial Peptide–Membrane Interactions

Kinetic analysis of peptide–membrane interactions generally involves a curve fitting process with no information about what the different curves may physically correspond to. Given the multistep process of peptide–membrane interactions, a computational method that utilizes physical parameters that relate to both peptide binding and membrane structure would provide new insight into this complex process. In this study, kinetic models accounting for two-state and three-state mechanisms were fitted to our previously reported simultaneous real-time measurements of mass and birefringence during the binding and dissociation of the peptide HPA3 (Hirst, D.; Lee, T.-H.; Swann, M.; Unabia, S.; Park, Y.; Hahm, K.-S.; Aguilar, M. Eur. Biophys. J. 2011, 40, 503−514); significantly, the mass and birefringence are constrained by the same set of kinetic constants, allowing the unification of peptide binding patterns with membrane structure changes. For the saturated phospholipid dimyristoyl-phosphatidylcholine (DMPC) the two-state model was sufficient to account for the observed changes in mass and birefringence, whereas for the unsaturated phospholipid 1-palmitoyl-2-oleoyl-<i>sn</i>-glycero-3-phosphocholine (POPC) the two-state model was found to be inadequate and a three-state model gave a significantly better fit. The third state of interaction for POPC was found to disrupt the bilayer much more than the previous two states. We propose a hypothesis for the mechanism of membrane permeabilization based on the results featuring a loosely bound first state, a tightly bound second state, and a highly membrane-disrupting third state. The results demonstrate the importance of the difference in membrane fluidity between the gel phase DMPC and the liquid crystal phase POPC for peptide–membrane interactions and establish the combination of DPI and kinetic modeling as a powerful tool for revealing features of peptide–membrane interaction mechanisms, including intermediate states between initial binding and full membrane disruption

Revisiting β-Casein as a Stabilizer for Lipid Liquid Crystalline Nanostructured Particles

Lipid liquid crystalline nanoparticles such as cubosomes and hexosomes have unique internal nanostructures that have shown great potential in drug and nutrient delivery applications. The triblock copolymer, Pluronic F127, is usually employed as a steric stabilizer in dispersions of lipid nanostructured particles. In this study, we investigated the formation, colloidal stability and internal nanostructure and morphology of glyceryl monooleate (GMO) and phytantriol (PHYT) cubosome dispersions on substituting β-casein with F127 in increasing proportion as the stabilizer. Internal structure and particle morphology were evaluated using small-angle X-ray scattering (SAXS) and cryo-transmission electron microscopy (cryo-TEM), while protein secondary structure was studied using synchrotron radiation circular dichroism (SRCD). The GMO cubosome dispersion stabilized by β-casein alone displayed a V2 (Pn3m) phase structure and a V2 to H2 phase transition at 60 °C. In comparison, F127-stabilized GMO dispersion had a V2 (Im3m) phase structure and the H2 phase only appeared at higher temperature, that is, 70 °C. In the case of PHYT dispersions, only the V2 (Pn3m) phase structure was observed irrespective of the type and concentration of stabilizers. However, β-casein-stabilized PHYT dispersion displayed a V2 to H2 to L2 transition behavior upon heating, whereas F127-stabilized PHYT dispersion displayed only a direct V2 to L2 transition. The protein secondary structure was not disturbed by interaction with GMO or PHYT cubosomes. The results demonstrate that β-casein provides steric stabilization to dispersions of lipid nanostructured particles and avoids the transition to Im3m structure in GMO cubosomes, but also favors the formation of the H2 phase, which has implications in drug formulation and delivery applications

Mutually Exclusive Interactions of Rifabutin with Spatially Distinct Mycobacterial Cell Envelope Membrane Layers Offer Insights into Membrane-Centric Therapy of Infectious Diseases

The mycobacterial cell envelope has spatially resolved inner and outer membrane layers with distinct compositions and membrane properties. However, the functional implication and relevance of this organization remain unknown. Using membrane biophysics and molecular simulations, we reveal a varied interaction profile of these layers with antibiotic Rifabutin, underlined by the structural and chemical makeup of the constituent lipids. The mycobacterial inner membrane displayed the highest partitioning of Rifabutin, which was located exclusively in the lipid head group/interfacial region. In contrast, the drug exhibited specific interaction sites in the head group/interfacial and hydrophobic acyl regions within the outer membrane. Altogether, we show that the design of membrane-active agents that selectively disrupt the mycobacterial outer membrane structure can increase drug uptake and enhance intracellular drug concentrations. Exploiting the mycobacterium-specific membrane–drug interaction profiles, chemotypes consisting of outer membrane-disruptive agents and antitubercular drugs can offer new opportunities for combinational tuberculosis (TB) therapy

Mutually Exclusive Interactions of Rifabutin with Spatially Distinct Mycobacterial Cell Envelope Membrane Layers Offer Insights into Membrane-Centric Therapy of Infectious Diseases

The mycobacterial cell envelope has spatially resolved inner and outer membrane layers with distinct compositions and membrane properties. However, the functional implication and relevance of this organization remain unknown. Using membrane biophysics and molecular simulations, we reveal a varied interaction profile of these layers with antibiotic Rifabutin, underlined by the structural and chemical makeup of the constituent lipids. The mycobacterial inner membrane displayed the highest partitioning of Rifabutin, which was located exclusively in the lipid head group/interfacial region. In contrast, the drug exhibited specific interaction sites in the head group/interfacial and hydrophobic acyl regions within the outer membrane. Altogether, we show that the design of membrane-active agents that selectively disrupt the mycobacterial outer membrane structure can increase drug uptake and enhance intracellular drug concentrations. Exploiting the mycobacterium-specific membrane–drug interaction profiles, chemotypes consisting of outer membrane-disruptive agents and antitubercular drugs can offer new opportunities for combinational tuberculosis (TB) therapy

Strongly Altered Receptor Binding Properties in PP and NPY Chimeras Are Accompanied by Changes in Structure and Membrane Binding^†^,^‡

Neuropeptide Y (NPY) and the pancreatic polypeptide (PP) are members of the neuropeptide Y family of hormones. They bind to the Y receptors with very different affinities:  Whereas PP is highly selective for the Y4 receptor, NPY displays highest affinites for Y1, Y2, and Y5 receptor subtypes. Introducing the NPY segment 19−23 into PP leads to an increase in affinity at the Y1 and Y2 receptor subtypes whereas the exchange of this segment from PP into NPY leads to a large decrease in affinity at all receptor subtypes. PP displays a very stable structure in solution, with the N terminus being back-folded onto the C-terminal α-helix (the so-called PP-fold). The helix of NPY is less stable and the N terminus is freely diffusing in solution. The exchange of this segment, however, does not alter the PP-fold propensities of the chimeric peptides in solution. The structures of the phospholipid micelle-bound peptides serving to mimic the membrane-bound species display segregation into a more flexible N-terminal region and a well-defined α-helical region. The introduction of the [19−23]-pNPY segment into hPP leads to an N-terminal extension of the α-helix, now starting at Pro14 instead of Met17. In contrast, a truncated helix is observed in [19-23hPP]-pNPY, starting at Leu17 instead of Ala14. All peptides display moderate binding affinities to neutral membranes (Kassoc in the range of 1.7 to 6.8 × 104 mol-1 as determined by surface plasmon resonance) with the differences in binding being most probably related to the exchange of Arg-19 (pNPY) by Glu-23 (hPP). Differences in receptor binding properties between the chimeras and their parental peptides are therefore most likely due to changes in the conformation of the micelle-bound peptides

Mutually Exclusive Interactions of Rifabutin with Spatially Distinct Mycobacterial Cell Envelope Membrane Layers Offer Insights into Membrane-Centric Therapy of Infectious Diseases

The mycobacterial cell envelope has spatially resolved inner and outer membrane layers with distinct compositions and membrane properties. However, the functional implication and relevance of this organization remain unknown. Using membrane biophysics and molecular simulations, we reveal a varied interaction profile of these layers with antibiotic Rifabutin, underlined by the structural and chemical makeup of the constituent lipids. The mycobacterial inner membrane displayed the highest partitioning of Rifabutin, which was located exclusively in the lipid head group/interfacial region. In contrast, the drug exhibited specific interaction sites in the head group/interfacial and hydrophobic acyl regions within the outer membrane. Altogether, we show that the design of membrane-active agents that selectively disrupt the mycobacterial outer membrane structure can increase drug uptake and enhance intracellular drug concentrations. Exploiting the mycobacterium-specific membrane–drug interaction profiles, chemotypes consisting of outer membrane-disruptive agents and antitubercular drugs can offer new opportunities for combinational tuberculosis (TB) therapy

Mutually Exclusive Interactions of Rifabutin with Spatially Distinct Mycobacterial Cell Envelope Membrane Layers Offer Insights into Membrane-Centric Therapy of Infectious Diseases

The mycobacterial cell envelope has spatially resolved inner and outer membrane layers with distinct compositions and membrane properties. However, the functional implication and relevance of this organization remain unknown. Using membrane biophysics and molecular simulations, we reveal a varied interaction profile of these layers with antibiotic Rifabutin, underlined by the structural and chemical makeup of the constituent lipids. The mycobacterial inner membrane displayed the highest partitioning of Rifabutin, which was located exclusively in the lipid head group/interfacial region. In contrast, the drug exhibited specific interaction sites in the head group/interfacial and hydrophobic acyl regions within the outer membrane. Altogether, we show that the design of membrane-active agents that selectively disrupt the mycobacterial outer membrane structure can increase drug uptake and enhance intracellular drug concentrations. Exploiting the mycobacterium-specific membrane–drug interaction profiles, chemotypes consisting of outer membrane-disruptive agents and antitubercular drugs can offer new opportunities for combinational tuberculosis (TB) therapy

Mutually Exclusive Interactions of Rifabutin with Spatially Distinct Mycobacterial Cell Envelope Membrane Layers Offer Insights into Membrane-Centric Therapy of Infectious Diseases

The mycobacterial cell envelope has spatially resolved inner and outer membrane layers with distinct compositions and membrane properties. However, the functional implication and relevance of this organization remain unknown. Using membrane biophysics and molecular simulations, we reveal a varied interaction profile of these layers with antibiotic Rifabutin, underlined by the structural and chemical makeup of the constituent lipids. The mycobacterial inner membrane displayed the highest partitioning of Rifabutin, which was located exclusively in the lipid head group/interfacial region. In contrast, the drug exhibited specific interaction sites in the head group/interfacial and hydrophobic acyl regions within the outer membrane. Altogether, we show that the design of membrane-active agents that selectively disrupt the mycobacterial outer membrane structure can increase drug uptake and enhance intracellular drug concentrations. Exploiting the mycobacterium-specific membrane–drug interaction profiles, chemotypes consisting of outer membrane-disruptive agents and antitubercular drugs can offer new opportunities for combinational tuberculosis (TB) therapy